LETTER
Access to 4-Substituted 2-Amino-4H-chromenes
1393
Table 4 Synthesis of 2-Amino-4-(4,4-dimethyl-2,6-dioxocyclo-
hexyl)-4H-chromene Derivatives 8a–h (continued)
Singh, V. K.; Bhunia, D. C.; Yadav, J. S. Tetrahedron Lett.
2009, 50, 3763.
(3) Hafez, E. A.; Elnagdi, M. H.; Elagamey, A. G. A.; El-
Taweel, F. M. A. A. Heterocycles 1987, 26, 903.
(4) (a) Limsuwan, S.; Trip, E. N.; Kouwen, T. R. M. H.;
Piersma, S.; Hiranrat, A.; Mahabusarakam, W.;
Entry Salicylaldehyde 1 Product 8a
Time Yield
(min) (%)b
I
Voravuthikkunchai, S. P.; Maarten von Dijl, J.; Kayser, O.
Phytomedicine 2009, 16, 645. (b) Bowers, W. S.; Ohta, T.;
Cleere, J. S.; Marsella, P. A. Science 1976, 193, 542.
(5) (a) Skommer, J.; Wlodkowic, D.; Mattö, M.; Eray, M.;
Pelkonen, J. Leukemia Res. 2006, 30, 322. (b) Rossi, A.;
Di Paola, R.; Mazzon, E.; Genovese, T.; Caminiti, R.;
Bramanti, P.; Pergola, C.; Koeberle, A.; Werz, O.; Sautebin,
L.; Cuzzocrea, S. J. Pharmacol. 2008, 329, 76.
I
CHO
OH
O
H1
I
6
60
85
O
I
H2
O
O
CN
1f
H2N
8f
(6) Hiramoto, J.; Nasuhara, A.; Michiloshi, K.; Kato, T.;
Kikugawa, K. Mutat. Res. 1997, 395, 47.
Cl
Cl
CHO
(7) Bianchi, G.; Tava, A. Agric. Biol. Chem. 1987, 51, 20.
(8) For reviews on indium Lewis acids, see: (a) Frost, C. G.;
Chauhan, K. K. J. Chem. Soc., Perkin Trans. 1 2000, 3015.
(b) Fringuelli, F.; Piermatti, O.; Pizzo, F.; Vaccaro, L. Curr.
Org. Chem. 2003, 7, 1661. (c) Frost, C. G.; Hartley, J. P.
Mini-Rev. Org. Chem. 2004, 1, 1.
(9) (a) Jayashree, P.; Shanthi, G.; Perumal, P. T. Synlett 2009,
917. (b) Shanthi, G.; Perumal, P. T. Tetrahedron Lett. 2007,
48, 6785. (c) Babu, T. H.; Perumal, P. T. Synlett 2011, 341.
(d) Shanthi, G.; Perumal, P. T. Synlett 2008, 2791.
(10) (a) Thirumurugan, P.; Perumal, P. T. Tetrahedron Lett.
2009, 50, 4145. (b) Thirumurugan, P.; Nandakumar, A.;
Muralidharan, D.; Perumal, P. T. J. Comb. Chem. 2010, 12,
161.
Cl
H1
7
8
60
60
83
84
OH
O
Cl
H2
CN
O
1g
H2N
8g
CHO
O
H1
MeO
O
OH
H2
OMe
O
CN
H2N
1h
8h
a The products were characterized by IR, NMR, MS, and elemental
analysis.
(11) Lakshmi, N. V.; Thirumurugan, P.; Perumal, P. T.
Tetrahedron Lett. 2010, 51, 1064.
(12) Lakshmi, N. V.; Thirumurugan, P.; Jayakumar, C.; Perumal,
P. T. Synlett 2010, 955.
b Isolated yield after recrystallization.
(13) (a) Thirumurugan, P.; Perumal, P. T. Tetrahedron 2009, 65,
7620. (b) Praveen, C.; Karthikeyan, K.; Perumal, P. T.
Tetrahedron 2009, 65, 9244.
Supporting Information for this article is available online at
(14) Lakshmi, N. V.; Thirumurugan, P.; Norrulla, K. M.;
Perumal, P. T. Bioorg. Med. Chem. Lett. 2010, 20, 5054.
(15) (a) Babu, G.; Perumal, P. T. Aldrichimica Acta 2000, 33, 16.
(b) Babu, G.; Perumal, P. T. Tetrahedron Lett. 1997, 38,
5025. (c) Babu, G.; Perumal, P. T. Tetrahedron 1998, 54,
1627. (d) Babu, G.; Nagarajan, R.; Natarajan, R.; Perumal,
P. T. Synthesis 2000, 661. (e) Shanthi, G.; Subbulakshmi,
G.; Perumal, P. T. Tetrahedron 2007, 63, 2057.
Acknowledgment
One of the authors (N.V.) thanks the Council of Scientific and Indu-
strial Research, New Delhi, India for a research fellowship.
References and Notes
(16) Experimental Procedure for the Synthesis of 2-Amino-
4H-chromene 4a (Table 2, Entry 1)
(1) (a) Batt, D. G. WO 2010009069, 2010. (b) Tjoeng, F. S.;
Carter, J.; Springer, J. R.; Zupec, M. E. WO 2006040676A1,
2006. (c) Cain, J. Nature (London) 1960, 188, 774.
To a stirred mixture of salicylaldehyde 1 (1 mmol) and
malononitrile (2, 1 mmol) in EtOH, 3-methyl-1-phenyl-1H-
pyrazol-5 (4H)-one (3, 1 mmol) and InCl3 (20 mol%) were
added. The reaction mixture was stirred until complete
conversion of the product as indicated by TLC (Table 2).
The solid formed was filtered, dried, and recrystallized from
EtOH to obtain the pure product in good yield (85%) 4a.
2-Amino-4-(5-hydroxy-3-methyl-1-phenyl-1H-pyrazol-
4-yl)-4H-chromene-3-carbonitrile (4a, Table 2, Entry 1)
White solid; mp 150–152 °C. IR (KBr): nmax = 3418, 3328,
3072, 2185, 1587 cm–1. 1H NMR (500 MHz, DMSO-d6): d =
1.94 (s, 3 H), 2.04 (s, 1 H, OH, D2O exchangeable), 4.78 (s,
1 H), 6.78 (s, 2 H, NH2, D2O exchangeable), 6.96 (d, 1 H,
J = 8.4 Hz), 7.01–7.06 (m, 2 H), 7.14–7.17 (m, 2 H), 7.38 (t,
2 H, J = 8.0 Hz), 7.68 (d, 2 H, J = 8.4 Hz). 13C NMR (125
MHz, DMSO-d6): d = 29.2, 31.2, 54.6, 115.8, 116.1, 119.1,
119.5, 121.2, 121.4, 123.2, 125.2, 125.5, 128.5, 129.4,
147.5, 149.1, 160.9. MS: m/z = 344.5 [M+]. Anal. Calcd (%)
for C20H16N4O2: C, 69.76; H, 4.68; N, 16.27. Found: C,
69.70; H, 4.72; N, 16.23.
(d) Torregroza, I.; Evans, T.; Das, C. B. Chem. Biol. Drug
Des. 2009, 3, 339. (e) Fatome, M.; Andrieu, L.; Laval, D. J.;
Clavel, M. J.; Blanco, L.; Guillaumel, J.; Rene, L.; Royer, R.
Eur. J. Med. Chem. 1977, 383.
(2) (a) Ramón, D. J.; Yus, M. Angew. Chem. Int. Ed. 2005, 44,
1602. (b) Zhu, J. Eur. J. Org. Chem. 2003, 1133. (c)Ugi, I.;
Domling, A.; Werner, B. J. Heterocycl. Chem. 2000, 37,
647. (d) Bienayme, H.; Hulme, C.; Oddon, G.; Schmitt, P.
Chem. Eur. J. 2000, 6, 3321. (e) Shinu, V. S.; Sheeja, B.;
Purushothaman, E.; Bahulayan, D. Tetrahedron Lett. 2009,
50, 4838. (f) Arabanian, A.; Mohammadnejad, M.; Balalaie,
S.; Gross, J. H. Bioorg. Med. Chem. Lett. 2009, 19, 887.
(g) Chebanov, V. A.; Muravyova, E. A.; Desenko, S. M.;
Musatov, V. I.; Knyazeva, I. V.; Shishkina, S. V.; Shishkin,
O. V.; Kappe, C. O. J. Comb. Chem. 2006, 8, 427.
(h) Dondoni, A.; Massi, A.; Sabbatini, S.; Bertolasi, V.
J. Org. Chem. 2002, 67, 6979. (i) Rashinkar, G.; Salunkhe,
R. J. Mol. Catal. A: Chem. 2010, 316, 146. (j) Srihari, P.;
Synlett 2011, No. 10, 1389–1394 © Thieme Stuttgart · New York